Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 20, Issue 3, 2001, Pages 202-205

  Casado, J L ^a   Lopez Velez, R ^a   Pintado, V ^a   Quereda, C ^a   Antela, A ^a   Moreno, S ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; MEGLUMINE ANTIMONATE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS LOAD; VISCERAL LEISHMANIASIS;

EID: 0035027302     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960100457     Document Type: Article

References (15)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
3. Discontinuation of PCP prophylaxis is safe in HIV-infected patients with immunological recovery with HAART. Preliminary results of an open, randomised and multicentric clinical trial (GESIDA 04/98)
4. The interaction of opportunistic infections and HIV replication
5. Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and leishmania in an area of Madrid, Spain
6. Treatment of visceral leishmaniasis in HIV-infected patients: A randomized trial comparing meglumine antimoniate with amphotericin B
7. Interferon gamma and interleukin 4 in human Leishmania donovani infections
8. IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma
9. Changes in interleukin 2 and interleukin 4 in asymptomatic human immunodeficiency virus-seropositive individuals
10. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from subjects coinfected with human immunodeficiency virus and Leishmania infantum
11. Switch from a type 2 to type 1 T helper cell response and cure established Leishmania major infection in mice induced by combined therapy with IL-2 and pentostam
12. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active antiretroviral therapy or HAART + IL-2
13. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
14. HIV viral load and response to antileishmanial chemotherapy in co-infected patients
15. Potential role for IL-10 in the immunosuppression associated with kala-azar